Literature DB >> 19701249

Target blood concentrations of CYA and tacrolimus in randomized controlled trials for the prevention of acute GVHD after hematopoietic SCT.

K Oshima, M Sato, K Terasako, S Kimura, S Okuda, S Kako, Y Kanda.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19701249     DOI: 10.1038/bmt.2009.213

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  4 in total

1.  Guest editorial: Role of monoclonal antibodies for the prevention and treatment of graft-versus-host disease.

Authors:  Yoshinobu Kanda
Journal:  Int J Hematol       Date:  2011-05-11       Impact factor: 2.490

2.  Population Pharmacokinetics and Initial Dosage Optimization of Tacrolimus in Pediatric Hematopoietic Stem Cell Transplant Patients.

Authors:  Xiao-Lin Liu; Yan-Ping Guan; Ying Wang; Ke Huang; Fu-Lin Jiang; Jian Wang; Qi-Hong Yu; Kai-Feng Qiu; Min Huang; Jun-Yan Wu; Dun-Hua Zhou; Guo-Ping Zhong; Xiao-Xia Yu
Journal:  Front Pharmacol       Date:  2022-07-06       Impact factor: 5.988

3.  Blood concentration of tacrolimus and age predict tacrolimus-induced left ventricular dysfunction after bone marrow transplantation in adults.

Authors:  Kohko Kanazawa; Masumi Iwai-Takano; Satoru Kimura; Tetsuya Ohira
Journal:  J Med Ultrason (2001)       Date:  2019-12-02       Impact factor: 1.314

4.  A prospective feasibility study of primary prophylaxis against invasive fungal disease with voriconazole following umbilical cord blood transplantation with fludarabine-based conditioning.

Authors:  Shinsuke Takagi; Hideki Araoka; Naoyuki Uchida; Yumiko Uchida; Daisuke Kaji; Hikari Ota; Aya Nishida; Kazuya Ishiwata; Masanori Tsuji; Hisashi Yamamoto; Tadaaki Ito; Naofumi Matsuno; Go Yamamoto; Yuki Asano-Mori; Masahiro Hayashi; Koji Izutsu; Kazuhiro Masuoka; Atsushi Wake; Shigeyoshi Makino; Akiko Yoneyama; Shuichi Taniguchi
Journal:  Int J Hematol       Date:  2014-03-25       Impact factor: 2.490

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.